BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

249 related articles for article (PubMed ID: 31270802)

  • 21. Inhibition of ocular neovascularization by novel anti-angiogenic compound.
    Gau D; Vignaud L; Francoeur P; Koes D; Guillonneau X; Roy P
    Exp Eye Res; 2021 Dec; 213():108861. PubMed ID: 34822853
    [TBL] [Abstract][Full Text] [Related]  

  • 22. VEGFR2 Trafficking by KIF13B Is a Novel Therapeutic Target for Wet Age-Related Macular Degeneration.
    Waters SB; Zhou C; Nguyen T; Zelkha R; Lee H; Kazlauskas A; Rosenblatt MI; Malik AB; Yamada KH
    Invest Ophthalmol Vis Sci; 2021 Feb; 62(2):5. PubMed ID: 33533881
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Fruquintinib inhibits VEGF/VEGFR2 axis of choroidal endothelial cells and M1-type macrophages to protect against mouse laser-induced choroidal neovascularization.
    Liu X; Guo A; Tu Y; Li W; Li L; Liu W; Ju Y; Zhou Y; Sang A; Zhu M
    Cell Death Dis; 2020 Nov; 11(11):1016. PubMed ID: 33247124
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Genetic deficiency and pharmacological modulation of RORα regulate laser-induced choroidal neovascularization.
    Liu CH; Yemanyi F; Bora K; Kushwah N; Blomfield AK; Kamenecka TM; SanGiovanni JP; Sun Y; Solt LA; Chen J
    Aging (Albany NY); 2023 Jan; 15(1):37-52. PubMed ID: 36626253
    [TBL] [Abstract][Full Text] [Related]  

  • 25. COL10A1 is a novel factor in the development of choroidal neovascularization.
    Lv D; Chen D; Wang Z; Cui Z; Ma JH; Ji S; Chen J; Tang S
    Microvasc Res; 2022 Jan; 139():104239. PubMed ID: 34520774
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Both Autocrine Signaling and Paracrine Signaling of HB-EGF Enhance Ocular Neovascularization.
    Inoue Y; Shimazawa M; Nakamura S; Takata S; Hashimoto Y; Izawa H; Masuda T; Tsuruma K; Sakaue T; Nakayama H; Higashiyama S; Hara H
    Arterioscler Thromb Vasc Biol; 2018 Jan; 38(1):174-185. PubMed ID: 29191924
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A novel vascular endothelial growth factor receptor 2 inhibitor, SU11248, suppresses choroidal neovascularization in vivo.
    Takahashi H; Obata R; Tamaki Y
    J Ocul Pharmacol Ther; 2006 Aug; 22(4):213-8. PubMed ID: 16910860
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Blockage of PI3K/mTOR Pathways Inhibits Laser-Induced Choroidal Neovascularization and Improves Outcomes Relative to VEGF-A Suppression Alone.
    Ma J; Sun Y; López FJ; Adamson P; Kurali E; Lashkari K
    Invest Ophthalmol Vis Sci; 2016 Jun; 57(7):3138-44. PubMed ID: 27304845
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Inhibition of choroidal neovascularization by homoisoflavanone, a new angiogenesis inhibitor.
    Kim JH; Kim JH; Yu YS; Jun HO; Kwon HJ; Park KH; Kim KW
    Mol Vis; 2008 Mar; 14():556-61. PubMed ID: 18385791
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Brivanib alaninate, a dual inhibitor of vascular endothelial growth factor receptor and fibroblast growth factor receptor tyrosine kinases, induces growth inhibition in mouse models of human hepatocellular carcinoma.
    Huynh H; Ngo VC; Fargnoli J; Ayers M; Soo KC; Koong HN; Thng CH; Ong HS; Chung A; Chow P; Pollock P; Byron S; Tran E
    Clin Cancer Res; 2008 Oct; 14(19):6146-53. PubMed ID: 18829493
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Circular RNA-ZBTB44 regulates the development of choroidal neovascularization.
    Zhou RM; Shi LJ; Shan K; Sun YN; Wang SS; Zhang SJ; Li XM; Jiang Q; Yan B; Zhao C
    Theranostics; 2020; 10(7):3293-3307. PubMed ID: 32194869
    [No Abstract]   [Full Text] [Related]  

  • 32. JNK inhibition reduces apoptosis and neovascularization in a murine model of age-related macular degeneration.
    Du H; Sun X; Guma M; Luo J; Ouyang H; Zhang X; Zeng J; Quach J; Nguyen DH; Shaw PX; Karin M; Zhang K
    Proc Natl Acad Sci U S A; 2013 Feb; 110(6):2377-82. PubMed ID: 23341606
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Inhibition of VEGF secretion and experimental choroidal neovascularization by picropodophyllin (PPP), an inhibitor of the insulin-like growth factor-1 receptor.
    Economou MA; Wu J; Vasilcanu D; Rosengren L; All-Ericsson C; van der Ploeg I; Menu E; Girnita L; Axelson M; Larsson O; Seregard S; Kvanta A
    Acta Ophthalmol; 2008 Nov; 86 Thesis 4():42-9. PubMed ID: 19032681
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Novel CCR3 Antagonists Are Effective Mono- and Combination Inhibitors of Choroidal Neovascular Growth and Vascular Permeability.
    Nagai N; Ju M; Izumi-Nagai K; Robbie SJ; Bainbridge JW; Gale DC; Pierre E; Krauss AH; Adamson P; Shima DT; Ng YS
    Am J Pathol; 2015 Sep; 185(9):2534-49. PubMed ID: 26188133
    [TBL] [Abstract][Full Text] [Related]  

  • 35. MLN4924 inhibits hedgehog signaling pathway and activates autophagy to alleviate mouse laser-induced choroidal neovascularization lesion.
    Xie L; Ji X; Tu Y; Wang K; Zhu L; Zeng X; Wang X; Zhang J; Zhu M
    Biomed Pharmacother; 2020 Oct; 130():110654. PubMed ID: 34321162
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Peripheral blood CD163(+) monocytes and soluble CD163 in dry and neovascular age-related macular degeneration.
    Daftarian N; Zandi S; Piryaie G; Nikougoftar Zarif M; Ranaei Pirmardan E; Yamaguchi M; Behzadian Nejad Q; Hasanpour H; Samiei S; Pfister IB; Soheili ZS; Nakao S; Barakat A; Garweg JG; Ahmadieh H; Hafezi-Moghadam A
    FASEB J; 2020 Jun; 34(6):8001-8011. PubMed ID: 32333612
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Amount of Mononuclear Phagocyte Infiltrate Does Not Predict Area of Experimental Choroidal Neovascularization (CNV).
    Will-Orrego A; Qiu Y; Fassbender ES; Shen S; Aranda J; Kotagiri N; Maker M; Liao SM; Jaffee BD; Poor SH
    J Ocul Pharmacol Ther; 2018 Sep; 34(7):489-499. PubMed ID: 30188257
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Antiangiogenic effects of tivozanib, an oral VEGF receptor tyrosine kinase inhibitor, on experimental choroidal neovascularization in mice.
    Kang S; Roh YJ; Kim IB
    Exp Eye Res; 2013 Jul; 112():125-33. PubMed ID: 23701975
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Role of Activating Transcription Factor 4 in Murine Choroidal Neovascularization Model.
    Yasuda H; Tanaka M; Nishinaka A; Nakamura S; Shimazawa M; Hara H
    Int J Mol Sci; 2021 Aug; 22(16):. PubMed ID: 34445595
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Comparative transcriptome analysis of human and murine choroidal neovascularization identifies fibroblast growth factor inducible-14 as phylogenetically conserved mediator of neovascular age-related macular degeneration.
    Wolf J; Schlecht A; Rosmus DD; Boneva S; Agostini H; Schlunck G; Wieghofer P; Lange C
    Biochim Biophys Acta Mol Basis Dis; 2022 Apr; 1868(4):166340. PubMed ID: 35032596
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.